Financials

	2025 *	2026 *
Net sales	28.16B 23.83B 21.74B 20.79B 38.5B 2,554B 39.84B 253B 100B 1,232B 106B 103B 4,347B	30.56B 25.86B 23.59B 22.56B 41.78B 2,772B 43.23B 275B 109B 1,337B 115B 112B 4,717B
Net income	1.13B 956M 872M 834M 1.54B 102B 1.6B 10.16B 4.03B 49.43B 4.24B 4.15B 174B	1.39B 1.18B 1.07B 1.03B 1.9B 126B 1.97B 12.53B 4.96B 60.91B 5.22B 5.11B 215B
Net Debt	10.92B 9.24B 8.43B 8.06B 14.94B 991B 15.45B 98.3B 38.94B 478B 40.97B 40.12B 1,686B	9.66B 8.18B 7.46B 7.13B 13.21B 876B 13.67B 86.95B 34.44B 423B 36.24B 35.49B 1,492B

* Estimated data More financial data

Company Profile

Employees

43,000

Sector

Medical Equipment, Supplies & Distribution

Calendar

02-25 - Q4 2025 Earnings Release

More about the company

Quotes

Date	Price	Change	Volume
18/02/26	47.71 $	+3.36%	1,504,571
17/02/26	46.16 $	+3.61%	1,707,923
13/02/26	44.55 $	-0.09%	1,186,727
12/02/26	44.59 $	-1.00%	3,824,644
11/02/26	45.04 $	-0.55%	2,216,712

Delayed Quote Nasdaq

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

47.71USD

Average target price

47.92USD

Spread / Average Target

+0.45%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Nasdaq Other stock markets 00:00:00 19/02/2026 +03			5-day change	1st Jan Change
47.71 ^USD	+3.36%		+5.93%	+13.60%

02-18	Lone Pine Capital LLC reports share stake in Spotify Technology, Medline, dissolves in Starbucks	RE
02-13	FDA says Medline identified electrical safety risks with Medline basic homecare beds	RE

Capitalization	39.7B 33.6B 30.65B 29.31B 54.29B 3,601B 56.17B 357B 142B 1,737B 149B 146B 6,129B	P/E ratio 2025 *	54.5x	P/E ratio 2026 *	44.3x
Enterprise value	50.63B 42.85B 39.09B 37.37B 69.23B 4,592B 71.63B 456B 180B 2,215B 190B 186B 7,815B	EV / Sales 2025 *	1.8x	EV / Sales 2026 *	1.62x
Free-Float	-	Yield 2025 *	0.8%	Yield 2026 *	0.54%

02-18	Lone Pine Capital LLC reports share stake in Spotify Technology, Medline, dissolves in Starbucks	RE
02-13	FDA says Medline identified electrical safety risks with Medline basic homecare beds	RE
02-06	Carlyle allays software fears, private-equity deals boost profit	RE
02-05	Tigress Initiates Medline at Buy With $55 Price Target	MT
02-03	TD Cowen Initiates Coverage on Medline With Buy Rating, $46 Price Target	MT
01-29	Nasdaq profit beats estimates; CEO touts IPO pipeline	RE
01-23	Goldman Sachs CEO David Solomon's 2025 compensation rises over 20%	RE
01-15	Medline Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 03:00 PM
01-13	Ranpak Expands Automation, Packaging Partnership With Medline	MT
01-13	JPMorgan profit beats estimates on trading boom, shares hit by weaker investment banking	RE
01-12	Sector Update: Health Care Stocks Mixed Late Afternoon	MT
01-12	Sector Update: Health Care	MT
01-12	FTI Consulting, Inc. Appoints Dan Scorpio and Heather Wilson as Senior Managing Directors	CI

02-05	Tigress Initiates Medline at Buy With $55 Price Target	MT
02-03	TD Cowen Initiates Coverage on Medline With Buy Rating, $46 Price Target	MT
01-12	Medline Poised to Leverage Business Model to Outsized Performance, RBC Says	MT
01-12	Medline Poised to Sustain High-Single Digit Organic Growth, BofA Says	MT
01-12	Morgan Stanley Initiates Coverage on Medline With Overweight Rating, $48 Price Target	MT

Medline Inc. Stock

Equities

MDLN

US58507V1070

Medical Equipment, Supplies & Distribution

Valuation: Medline Inc.

Chart: Medline Inc.

Latest news: Medline Inc.

Last Transcript: Medline Inc.

Analysts' recommendations: Medline Inc.

Press Releases: Medline Inc.

News in other languages: Medline Inc.

Quotes and Performance

Course Extremes

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Quarterly revenue - Rate of surprise

02-18	Medline announces participation in the Barclays 28th Annual Global Healthcare Conference	GL
01-28	Medline to report fourth quarter and full year 2025 results on February 25, 2026	GL
01-02	Fitch Upgrades Medline to 'BBB-'; Outlook Stable	AQ
12-31	Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference	GL
12-19	Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares	GL

01-15	Florierendes Investmentbanking gibt Morgan Stanley Schwung
01-13	JPMorgan-Le bénéfice dépasse les attentes au T4, mais la carte Apple pèse
12-18	Bourse : EssilorLuxottica conserve Burberry, Bernard Arnault rempile pour 10 ans, ça bouge chez BP
12-18	Oracle n'est plus prophète en son pays
12-17	Wall Street : Medline bondit pour sa première cotation, signant la plus grosse IPO depuis quatre ans

1 day	+3.36%
1 week	+5.93%
Current month	+7.94%
1 month	+8.14%
Current year	+13.60%

1 week	44.03	48.17
1 month	42.2	48.17
Current year	38.5	48.17
1 year	34.89	48.17
3 years	34.89	48.17
5 years	34.89	48.17
10 years	34.89	48.17

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
MEDLINE INC.	+3.36%	+5.93%	-	-	38.41B
ABBOTT LABORATORIES	+0.92%	-0.26%	-12.97%	+6.14%	195B
MEDTRONIC PLC	+2.16%	-2.56%	+14.43%	+16.14%	124B
CENCORA, INC.	+0.07%	-1.50%	+49.20%	+123.07%	70.03B
HOYA CORPORATION	+1.14%	-3.58%	+47.81%	+104.62%	60.35B
BECTON, DICKINSON AND COMPANY	+2.99%	+1.14%	-18.86%	-25.29%	50.51B
DEXCOM, INC.	+3.37%	+6.82%	-19.58%	-36.56%	27.11B
STERIS PLC	+1.61%	+2.42%	+13.52%	+31.47%	24.07B
SARTORIUS STEDIM BIOTECH	+2.61%	+0.89%	-15.04%	-47.04%	19.64B
ZIMMER BIOMET HOLDINGS, INC.	+1.13%	+2.76%	-3.85%	-22.01%	19.26B
Average	+1.94%	+1.46%	+6.07%	+16.73%	62.82B
Weighted average by Cap.	+1.60%	+0.13%	+6.87%	+25.89%